Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07063420 · ClinicalTrials.gov registry record · NA
Patient Centered Multi-Agent Decision Support System (PCM-DSS) for Healthcare Providers
A NA study of Type 2 Diabetes Treated With Insulin, sponsored by Daniel Chernavvsky, MD.
- Recruiting
- Registry status
- NA
- Development phase
- 18
- Enrollment target
- 1
- Study location
NCT07063420: Recruiting NA study of Type 2 Diabetes Treated With Insulin, sponsored by Daniel Chernavvsky, MD.
NCT07063420 is a NA study of Type 2 Diabetes Treated With Insulin that is actively recruiting participants, run by Daniel Chernavvsky, MD. The registered enrollment target is 18 participants, below the 303-participant average among 3 other Type 2 Diabetes Treated With Insulin trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07063420, a NA study of Type 2 Diabetes Treated With Insulin, is actively recruiting participants, sponsored by Daniel Chernavvsky, MD.
- RECRUITING
- Registry status
- NA
- Development phase
- 18 participants
- Enrollment target
- 1
- Study location
Study Summary
Decision Support System (Software) for multi antidiabetic drug therapy use in type 2 diabetes (T2D).
Primary Outcome
Measured by improved glycemic control (HbA1c change and CGM-derived metrics).
Conditions Studied
Interventions
- OTHER Continuous Glucose Monitor (CGM) + Patient Centered Multi-Agent Decision Support System (PCM-DSS)
- OTHER Continuous Glucose Monitor (CGM) + Usual Care
Study Locations (1)
Virginia
- University of Virginia Center for Diabetes Technology - Charlottesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2025-10-28 |
| Est. Completion | 2026-07-31 |
| Phase | NA |
What NCT07063420 shows while recruiting
NCT07063420 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 18 participants, a relatively small participant target, below the 303-participant average among 3 other Type 2 Diabetes Treated With Insulin trials with a reported enrollment target (94% lower).
The record links to 1 condition, with Type 2 Diabetes Treated With Insulin appearing as the primary indexed condition, and to 2 interventions - of which Continuous Glucose Monitor (CGM) + Patient Centered Multi-Agent Decision Support System (PCM-DSS) is the first listed.
NCT07063420 reports a single indexed study location in Virginia.
Frequently Asked Questions
What is clinical trial NCT07063420 about?
NCT07063420 is a clinical study titled "Patient Centered Multi-Agent Decision Support System (PCM-DSS) for Healthcare Providers". Decision Support System (Software) for multi antidiabetic drug therapy use in type 2 diabetes (T2D).
What is the current status of trial NCT07063420?
This trial is currently recruiting. It is a NA study. The enrollment target is 18 participants. The study started on 2025-10-28. Estimated completion is 2026-07-31.
What conditions does trial NCT07063420 study?
This clinical trial studies the following conditions: Type 2 Diabetes Treated With Insulin.
What interventions are being tested in trial NCT07063420?
The interventions under investigation include: Continuous Glucose Monitor (CGM) + Patient Centered Multi-Agent Decision Support System (PCM-DSS) (OTHER), Continuous Glucose Monitor (CGM) + Usual Care (OTHER).
Who is sponsoring clinical trial NCT07063420?
This trial is sponsored by Daniel Chernavvsky, MD, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07063420 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Type 2 Diabetes Treated With Insulin
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01245179 · 18 participants · Phase 1
Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease
- NCT01999361 · 18 participants · NA
Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss
- NCT02359825 · 18 participants · Phase 1
Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function
- NCT02870244 · 18 participants · Phase 1
Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI